Loading data
AGIGNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 410.63 k USD | 560.18 k USD | 794.03 k USD | 1.64 m USD | 1.33 m USD |
| Research and development expense | 752.29 k USD | 1.65 m USD | — | — | — |
| Operating profit | -28.75 m USD | -8.05 m USD | -4.58 m USD | -777.92 k USD | -1.03 m USD |
| Interest expense | 400 k USD | 400 k USD | — | — | 296 USD |
| Profit before tax | -29.46 m USD | -3.62 m USD | -3.21 m USD | -744.28 k USD | 1.02 m USD |
| Net income (reported basis) | -29.45 m USD | -3.61 m USD | -3.21 m USD | -740 k USD | -1.02 m USD |
| Net income attributable to common shareholders | -29.45 m USD | -3.61 m USD | — | -744.28 k USD | -1.06 m USD |
| Basic earnings per share | -0.9 USD/share | -0.11 USD/share | -0.3 USD/share | 0.07 USD/share | -0.11 USD/share |
| Diluted earnings per share | -0.9 USD/share | -0.11 USD/share | -0.3 USD/share | 0.07 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.